EcoDrugPlus

Elastase, Neutrophil Expressed

Ensembl ID : ENSODEG00000011098
Gene Symbol: ELANE
3 Cross references
102 Possible Orthologues:

Endothelial Pas Domain Protein 1

Ensembl ID : ENSODEG00000011675
Gene Symbol: EPAS1
3 Cross references
222 Possible Orthologues:

Endothelin Converting Enzyme 1

Ensembl ID : ENSODEG00000016105
Gene Symbol: ECE1
3 Cross references
230 Possible Orthologues:

Endothelin Receptor Type A

Ensembl ID : ENSODEG00000002616
Gene Symbol: EDNRA
3 Cross references
263 Possible Orthologues:

Endothelin Receptor Type B

Ensembl ID : ENSODEG00000005525
Gene Symbol: EDNRB
3 Cross references
264 Possible Orthologues:

Epidermal Growth Factor Receptor

Ensembl ID : ENSODEG00000001111
Gene Symbol: EGFR
1 Cross references
285 Possible Orthologues:

Epoxide Hydrolase 2

Ensembl ID : ENSODEG00000007405
Gene Symbol: EPHX2
1 Cross references
203 Possible Orthologues:

Erb-B2 Receptor Tyrosine Kinase 2

Ensembl ID : ENSODEG00000017915
Gene Symbol: ERBB2
3 Cross references
200 Possible Orthologues:

Erb-B2 Receptor Tyrosine Kinase 3

Ensembl ID : ENSODEG00000008152
Gene Symbol: ERBB3
3 Cross references
282 Possible Orthologues:

Erb-B2 Receptor Tyrosine Kinase 4

Ensembl ID : ENSODEG00000009033
Gene Symbol: ERBB4
3 Cross references
236 Possible Orthologues:

Estrogen Receptor 1

Ensembl ID : ENSODEG00000001036
Gene Symbol: ESR1
3 Cross references
210 Possible Orthologues:

Estrogen Receptor 2

Ensembl ID : ENSODEG00000014359
Gene Symbol: ESR2
3 Cross references
273 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).